United StatesMeclizine Hydrochloride Tablets, USP 12.5 mg—50 Tablets (5 x 10, NDC 60687-775-65) and 12.5 mg Individual Dose (NDC 60687-775-11), Lot #1024852, Exp 9/30/2026, distributed by American Health Packaging (Columbus, OH) and recalled by Amerisource Health Services LLC. The product was recalled nationwide in the U.S. because it failed tablet specifications.
What's being recalled
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Recalling firm: Amerisource Health Services LLC, Columbus, OH, United States.
How to identify it
Lot #1024852; Exp 9/30/2026
The hazard
Failed tablet specifications.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)